期刊文献+

梯度洗脱HPLC法测定甲磺酸伊马替尼含量及有关物质 被引量:11

Determination of imatinib mesylate and related substances by gradient elution HPLC
下载PDF
导出
摘要 目的建立甲磺酸伊马替尼原料药含量测定和有关物质检查方法。方法采用Herdera C18(5μm,4.6mm×250mm)色谱柱,甲醇-辛烷磺酸钠水溶液,梯度洗脱,流速为1mL.min-1,检测波长为267nm,进样体积为20μL,柱温为40℃。结果在选定色谱条件下,主要合成的中间体和各降解产物可以完全分离。线性范围8.12~81.20μg.L-1(r=0.9999),检测限为0.02μg.mL-1。结论所用方法准确、灵敏、可靠。 OBJECTIVE A method for determination of Imatinib mesylate and related substances was established.METHODS The liquid chromatography was carried out using a Herdera C18(5μm,4.6mm×250mm)column.The mobile phase consisted of methanol-solution of 1-octanesulfonic acid sodium salt(36mmol·L-1),gradient elution.The flow rate was 1mL·min-1.The detection wavelength was 278nm.The injection volume was 20μL.The column temperature was 40℃.RESULTS The intermediates and degraded substances could be separated.Three batches of sample were determined.The calibration curve for Imatinib mesylate was linear in the range of 8~80μg·L-1(r=0.9999).The detection limit for Imatinib mesylate was 0.02μg·mL-1.CONCLUSION The method is specific,accurate,sensitive,simple,and can be used for quality control of Imatinib mesylate.
出处 《海峡药学》 2012年第3期58-60,共3页 Strait Pharmaceutical Journal
关键词 甲磺酸伊马替尼 有关物质 含量测定 HPLC Imatinib mesylate Related substances Determination HPLC
  • 相关文献

参考文献4

二级参考文献37

  • 1王海江,杨新辉.甲磺酸伊马替尼治疗手术后复发和/或转移的胃肠道间质瘤的疗效分析[J].新疆医科大学学报,2008,31(12):1716-1717. 被引量:1
  • 2《卫生部颁药品标准》二部第四册.
  • 3《USP30》.
  • 4《EP6.0》.
  • 5Mussi C, Ronellenfitsch U , Jakob J, et al. Post - imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients? Annals of Oncology, 2009,10 : 1093.
  • 6Eisenberg BL, Harris J, Blanke CD,et al. Phase Ⅱ trial of neoadjurant/adjuvant imatinib mesylatc (IM) for advanced primary and meta-static/recurrent operable gastrointestinal stromal tumor (GIST) : early results of RTOG 0132/ACRIN 6665. J Surg Oncol, 2009,99( 1 ) :42 -47.
  • 7E isenburg BL,Judson I. Surgery and imatinib in the management of GIST: Emerging approaches to adjuvant and neoadjuvant therapy. Annals of Surgical Oneoloy, 2004,11 (5) :465 - 475.
  • 8Miettinen M, Lasota J. Gastrointestinal stromal tumors definition, clinical,histological,immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch ,2001,438 ( 1 ) : 1.
  • 9Rankin C, Yon Mehren M, Blanke C, et al. Dose efect of imatinib in patients wi th metastatic GIST- Phase Ⅲ Sarcoma Group Study S0033. Proc Am Soc Clin Oncol, 2004,23:815.
  • 10Kikuchi H, Yamamoto M, Hiramatsu Y, et al. Effect of loss of heterozygosity of the c - kit gene on prognosis after hepatectomy for metastatic liver gastrointestinM stromal tumors. Cancer Sci ,2007 ,98 ( 11 ) : 1734 - 1739.

共引文献15

同被引文献91

引证文献11

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部